TheraBionic Device

DEVICE3 trials

Sponsors

University of Sao Paulo, Wake Forest University Health Sciences, THERABIONIC INC.

Conditions

Advanced Hepatocellular CarcinomaHepatocellular Carcinoma

Phase 1

Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma

CompletedNCT00534664

University of Sao PauloAdvanced Hepatocellular Carcinoma

Start: 2005-10-31End: 2007-02-28Updated: 2007-09-26

Phase 2

Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

WithdrawnNCT04526080

Wake Forest University Health SciencesHepatocellular Carcinoma

Start: 2021-04-30End: 2022-11-30Updated: 2021-02-26

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

THERABIONIC INC.Hepatocellular Carcinoma

Start: 2023-07-31End: 2024-10-30Target: 166Updated: 2023-06-28

Related Papers

The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments.

2024-07-243 citations